Zura Bio (ZURA) EBIT (2022 - 2026)
Zura Bio (ZURA) posted quarterly EBIT of -$25.5 million for Q1 2026, down 32.43% year-over-year from -$37.7 million in Q1 2025, and down 38.5% quarter-over-quarter from -$18.4 million in Q4 2025.
Zura Bio (ZURA) EBIT (2022 - 2026) Analysis & Trends
Zura Bio's EBIT history runs 5 years deep, the most recent figure standing at -$25.5 million for Q1 2026.
- In Q1 2026, EBIT fell 32.43% year-over-year to -$25.5 million; the TTM figure through Mar 2026 stood at -$81.5 million (down 23.35% YoY), while the FY2025 annual figure was -$75.2 million, down 36.34% from the prior year.
- EBIT for Q1 2026 stood at -$25.5 million, down from -$18.4 million in the prior quarter.
- The five-year high for EBIT was -$927000.0 in Q2 2022, with the low at -$33.9 million in Q2 2023.
- The 5-year median for EBIT is -$15.7 million (2024), against an average of -$14.5 million.
- The sharpest annual moves came in 2023 and 2024: EBIT plunged 3557.5% in 2023, then soared 65.32% in 2024.
- Zura Bio's EBIT stood at -$17.3 million in 2022, then soared by 37.59% to -$10.8 million in 2023, then sank by 45.3% to -$15.7 million in 2024, then declined by 17.03% to -$18.4 million in 2025, then plunged by 38.5% to -$25.5 million in 2026.
- Business Quant data shows ZURA's EBIT at -$25.5 million in Q1 2026, -$18.4 million in Q4 2025, and -$19.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | -29.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.32 Mn |
| Mar 31, 2026 | -25.50 Mn |
| Dec 31, 2025 | -18.41 Mn |
| Sep 30, 2025 | -19.52 Mn |
| Jun 30, 2025 | -18.06 Mn |
| Mar 31, 2025 | -19.25 Mn |
| Dec 31, 2024 | -15.73 Mn |
| Sep 30, 2024 | -19.32 Mn |
| Jun 30, 2024 | -11.76 Mn |
| Mar 31, 2024 | -8.38 Mn |
| Dec 31, 2023 | -10.83 Mn |
| Sep 30, 2023 | -10.19 Mn |
| Jun 30, 2023 | -33.91 Mn |
| Mar 31, 2023 | -7.72 Mn |
| Dec 31, 2022 | -17.35 Mn |
| Sep 30, 2022 | -1.07 Mn |
| Jun 30, 2022 | -927,000.00 |
| Mar 31, 2022 | -7.82 Mn |